SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-16-003414
Filing Date
2016-02-16
Accepted
2016-02-16 16:43:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO THE SCHEDULE 13G sc13ga307422022_02162016.htm SC 13G/A 273925
2 JOINT FILING AGREEMENT ex991to13ga307422022_021616.htm EX-99.1 46122
  Complete submission text file 0000921895-16-003414.txt   321818
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Subject) CIK: 0001261734 (see all company filings)

IRS No.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-79369 | Film No.: 161429555
SIC: 2834 Pharmaceutical Preparations